Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.

Show other versions (1)

BACKGROUND: Metformin reduces cardiovascular risk in patients with type 2 diabetes seemingly independent of lowering blood glucose concentration. We assessed the cardiovascular effects of metformin in individuals without type 2 diabetes. METHODS: We did a single-centre, double-blind, placebo-control...

书目详细资料
Main Authors:	Preiss, D, Lloyd, S, Ford, I, McMurray, J, Holman, R, Welsh, P, Fisher, M, Packard, C, Sattar, N
格式:	Journal article
语言:	English
出版:	2014

相似书籍

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): A randomised controlled trial
由: Preiss, D, et al.
出版: (2014)

Metformin therapy and circulating NT-proBNP levels: the CAMERA trial
由: Preiss, D, et al.
出版: (2016)

Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study: Metabolism
由: Preiss, D, et al.
出版: (2016)

Putative miRNA biomarkers of insulin resistance and the effect of metformin: data from the CAMERA trial
由: ALRamah, T, et al.
出版: (2017)

Associations of targeted circulating microRNAs with insulin resistance in the CAMERA (Carotid Atherosclerosis: MEtformin for insulin ResistAnce) trial
由: Alramah, T, et al.
出版: (2019)

The sustained influence of metformin therapy on circulating GLP-1 levels in individuals with and without type 2 diabetes
由: Preiss, D, et al.
出版: (2016)

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored.
由: McMurray, J, et al.
出版: (2014)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
由: Wamil, M, et al.
出版: (2020)

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
由: Holman, R, et al.
出版: (2017)

Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure
由: Preiss, D, et al.
出版: (2016)

Research digest: CV trials in diabetes — Looking ahead
由: Preiss, D, et al.
出版: (2018)

Myoinositol and Metformin versus Only Metformin in the Management of Gestational Diabetes Mellitus: A Randomised Open-label Clinical Trial
由: Palash Mazumder, et al.
出版: (2023-04-01)

METFORMIN IN THE MANAGEMENT OF TYPE-2 DIABETES - REPLY
由: Holman, R, et al.
出版: (1989)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
由: Holman, R
出版: (2007)

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
由: Wamil, M, et al.
出版: (2020)

Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future.
由: Rankin, N, et al.
出版: (2016)

Effect of Valsartan on the Incidence of Diabetes REPLY
由: Holman, R, et al.
出版: (2010)

Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study.
由: Preiss, D, et al.
出版: (2014)

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials
由: Stevens, R, et al.
出版: (2012)

Prediabetes and the risk of diabetes.
由: McMurray, J, et al.
出版: (2012)

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
由: Kristensen, SL, et al.
出版: (2019)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
由: Wamil, M, et al.
出版: (2021)

Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.
由: Rémy Boussageon, et al.
出版: (2012-01-01)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
由: Cull, C, et al.
出版: (1995)

Dalcetrapib reduces risk of new-onset diabetes in patients with coronary heart disease
由: Schwartz, GG, et al.
出版: (2020)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
由: Stevens, R, et al.
出版: (2005)

UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes
由: Wright, A, et al.
出版: (1998)

Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: A randomised blinded trial
由: Elahe Mesdaghinia, et al.
出版: (2013-01-01)

Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial
由: Mauro Chiarito, et al.
出版: (2023-02-01)

SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
由: Sattar, N, et al.
出版: (2016)

Metformin and Bee Venom Enhanced Histological Changes of the Pancreas in Diabetic Mice
由: Rana, et al.
出版: (2022-09-01)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
由: Holman, R, et al.
出版: (2001)

Change in levels of physical activity after diagnosis of type 2 diabetes: An observational analysis from the NAVIGATOR study
由: Preiss, D, et al.
出版: (2014)

Exploring the Effect of Exercise versus Metformin on Insulin Resistance amongst Nigerians with Pre-diabetes: A Randomised Controlled Trial
由: Umar Musa Tambuwal, et al.
出版: (2024-09-01)

Transplantation and diabetes (Transdiab): a pilot randomised controlled trial of metformin in impaired glucose tolerance after kidney transplantation
由: Basil Alnasrallah, et al.
出版: (2019-04-01)

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT
由: Griffin, SJ, et al.
出版: (2018)

Risk factors for coronary heart disease in non-insulin dependent diabetic subjects
由: Turner, R, et al.
出版: (1996)

Metformin and risk of cardiovascular disease.
由: Turner, R, et al.
出版: (1999)

Comparison of Nisha-amalaki and Metformin in Overweight and Obese Patients with Type 2 Diabetes Mellitus (Madhumeha): A Randomised Controlled Trial
由: Aman Chhabra, et al.
出版: (2024-03-01)

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT
由: Simon J Griffin, et al.
出版: (2018-04-01)